Drug may ease Alzheimer’s-related memory defects

	Tweet

If experiments in mice with a form of Alzheimer’s disease are any indication, treatment with a drug called rolipram appears to produce lasting improvement in learning and memory deficits, investigators from New York report.

Rolipram is being studied for treating a number of conditions ranging from depression to multiple sclerosis, even spinal cord injuries. The researchers theorize that it may stabilize synaptic circuits—the connections between nerves.

"This is the first demonstration that treatment with an agent known to directly affect the molecular machinery of memory can lead to long-lasting strengthening of the connection between nerve cells, and protect them from damage by beta-amyloid, the molecule responsible for cellular damage in Alzheimer’s disease,” Dr. Ottavio Arancio told Reuters Health.

Arancio, of Columbia University’s Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, and his colleagues describe their studies in the Journal of Clinical Investigation.

Briefly, they saw that one 3-week course of rolipram injections improved abnormalities in synapses, learning, and memory in mice engineered to develop a form Alzheimer’s disease.

“Rolipram re-establishes normal memory” in these animals, Arancio said. “Significantly, this improvement persisted for at least two months after drug treatment was stopped.”

It is noteworthy, he added, that rolipram’s beneficial effects are actually greater in older animals.

“This work suggests that not only can treatment with rolipram ... counteract the toxic effects of high levels of amyloid protein in Alzheimer’s disease, but that it has the potential to delay the natural progression of the disease,” Arancio concluded.

SOURCE: Journal of Clinical Investigation, December 1, 2004.

RELATED STORIES:
Patients who stop using statins after stroke increase risk of death   Memory Training Might Not Be Best for Reducing “Senior Moments”   Course correction needed for Alzheimer’s therapies, experts warn   X-Rays for Early Alzheimer’s Disease Detection   First Atomic-Level Look at a Protein That Causes Brain Disease   High Levels of Vitamin D In the Body May Decrease the Risk of Multiple Sclerosis   Early Treatment Delays Multiple Sclerosis Progression   Using amphetamines may increase risk of Parkinson’s disease   Vertigo Linked to Osteoporosis   Smoking years key factor in lower Parkinson’s risk   Botox injections reduce voice tremor   Walking slows progression of Alzheimer’s

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]